ReviewCNS drugs2021
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status.
Ioline D Henter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
85 papers cite itlatest 60 shown
this paperpooled ittrialcites it